| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04726501 | CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma | Hodgkin Lymphoma | Active, Not Recruiting |
| Phase 3 | |||
| NCT05681260 | Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly… | T-cell Lymphoblastic Lymphoma | Recruiting |
| NCT02845882 | LBL-2016 for Children or Adolescents in China | Lymphoblastic Lymphoma | Active, Not Recruiting |
| NCT04881838 | CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL | Pediatric Anaplastic Large Cell Lymphoma | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06563245 | Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment | Classical Hodgkin Lymphoma | Recruiting |
| NCT07168980 | Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents | Mature B-cell Non-Hodgkin Lymphoma | Recruiting |
| NCT02405676 | BNHL-2015 for Children or Adolescents in China | Mature B-cell Non-Hodgkin Lymphoma | Active, Not Recruiting |
| Not specified | |||
| NCT02959086 | Shanghai Epidemiology Study for Adolescents and Children with Cancer | Childhood Cancer | Recruiting |